drugset / Trial / NCT03844217

Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers

NCT03844217

SequentialOpen-labelDiagnostic

Summary

This study investigates stimulation of the posterior pituitary gland by oral Macimorelin (a ghrelin receptor Agonist) to be a novel diagnostic test in the polyuria-polydipsia syndrome.

Timeline

Start
2019-03-07
Primary completion
2019-07-16
Completion
2019-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Macimorelin Small molecule 0.5 mg/kg Oral
Subject Macimorelin Small molecule 0.75 mg/kg Oral

Indications

No indication recorded.